14.34USD-1.85%Mkt Cap: 873.30M USDP/E: —Last update: 2026-06-01
Janux Therapeutics, Inc., a clinical stage biopharmaceutical company, develops immunotherapies based on Tumor Activated T Cell Engager (TRACTr), Tumor Activated Immunomodulator (TRACIr), and Adaptive Immune Response Modu…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap873.30M USD
Enterprise Value-45.05M USD
Revenue (TTM)13.73M USD
Gross Profit-113.92M USD
Net Income (TTM)-113.63M USD
Revenue/Share0.2210 USD
Last Price14.34 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees108
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-5.26
PEG—
EV/EBITDA0.29
EV/Revenue-3.28
P/S64.79
P/B0.94
EPS (TTM)-1.84
EPS (Forward)-2.77
52W Range
12.1210% of range35.34
52W High35.34 USD
52W Low12.12 USD
Profitability
Gross Margin0.00%
Oper. Margin-916.50%
EBITDA Margin0.00%
Profit Margin-1136.25%
ROE-11.88%
ROA-11.34%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-82.23M USD
CapEx (TTM)1.04M USD
FCF Margin-393.29%
FCF Yield-6.18%
Net Debt-934.81M USD
Net Debt/EBITDA6.03
Balance Sheet
Debt/Equity0.02
Current Ratio17.01
Quick Ratio16.95
Book Value/Sh15.47 USD
Cash/Share15.68 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)40.56 USD
Target Range14.00 USD – 80.00 USD
# Analysts16
Ownership
Shares Out.60.98M
Float39.20M
Insiders6.73%
Institutions102.67%
Short Interest
Short Ratio8.2d
Short % Float16.44%
Short % Out.12.83%
Shares Short7.83M
Short (prev mo.)7.44M
Technical
SMA 5014.49 (-1.0%)
SMA 20018.82 (-23.8%)
Beta2.57
S&P 52W Chg27.94%
Avg Vol (30d)970.76K
Avg Vol (10d)1.12M
Technical Indicators
RSI (14)52.6
MACD-0.0083
MACD Signal-0.0577
MACD Hist.+0.0495
BB Upper14.86 USD
BB Middle14.37 USD
BB Lower13.88 USD
BB Width6.79%
ATR (14)0.5444 USD
Vol Ratio (20d)0.67x